Literature DB >> 19586082

Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.

Irina Cleemput, Nancy Thiry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19586082     DOI: 10.2165/00019053-200927050-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  2 in total

1.  Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.

Authors:  Lieven Annemans; Vanessa Rémy; James Oyee; Nathalie Largeron
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

2.  Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.

Authors:  Nancy Thiry; Chris De Laet; Frank Hulstaert; Mattias Neyt; Michel Huybrechts; Irina Cleemput
Journal:  Int J Technol Assess Health Care       Date:  2009-04       Impact factor: 2.188

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.